Searched for
AMI LIFESCIENCES
These large- and mid-cap stocks can give more than 30% return in 1 year, according to analystsIf market volatility is worrying you, just consider three things. An earnings season is set to start; valuations are not cheap; and last, b...- Rang barse! 56 multibagger stocks defy market slump, soar up to 760% since last HoliDespite market volatility, 56 stocks have retained multibagger status, delivering up to 760% returns since March 2024. Smallcaps like Ashik...
- The power of patience: How long-term investing drives superior returnsIndia's growth at 10% annually while maintaining 15% return ratios is becoming challenging, especially for large caps. A decade ago, 30 com...
- These mid-cap stocks with ‘strong buy’ & ‘buy’ recos can rally over 25%, according to analystsWhile every earnings season is important, sometimes a particular season becomes critical because it provides a clear picture of what is hap...
- Stock market update: Nifty Pharma index 0.94%The Nifty Pharma index closed 0.94 per cent at 23011.10.
- Stock market update: Nifty Pharma index 0.73% in a weak marketThe Nifty Pharma index was trading 0.73 per cent at 22437.05.
- BEML, GRSE among 76 stocks to trade ex-dividend tomorrow. Do you own any?State-owned BEML and Garden Reach Shipbuilders (GRSE), along with 74 other companies, are expected to be in the spotlight today as they hav...
- Vedanta, BEML, among 140 stocks to remain in focus next week for dividend, bonus, split. Do you own any?The record date is the date set by the company to decide the shareholders who are eligible to receive the offer. To be eligible for a buyba...
- Pharma raw material makers in race to tank up on CXO talentSome of these PE-owned platform companies include Advent International-led Cohance Lifesciences / Suven Pharma, PAG and CX Partners-funded ...
- Ami Lifesciences appoints Amit Kaptain as CEOAs part of the Ami Lifesciences senior management team, Kaptain will be responsible for building business strategy and longstanding global ...
- More than half of 2021 debutants giving positive returns, 5 still hold multibagger statusOut of 64 companies listed in 2021, 34 are trading above their respective issue prices, with at least six of them still trading more than 1...
- Over 60 IPOs came out in 2021; here’s what to buy now"Look for companies which are benefiting from the China plus strategy in the API, CRAMS segment in the chemical and pharmaceutical segments...
- 30 cos may float public issues in Oct-Nov to mop up Rs 45,000 crGoing forward, the IPO boom is expected to extend in the coming year if the prevailing market situation remains constant or doesn't change ...
- India Inc seeks Rs 20,000 crore more in IPO seasonCompanies usually time their IPO launches based on the market sentiment and investor appetite for these share sales. Bankers said if the mo...
- Aptus Value Housing, CarTrade, 4 others get Sebi's go-ahead to float IPOThe six firms, which had filed their respective preliminary IPO papers with the markets regulator between May and June, obtained their obse...
- India-focussed Kedaara set to close $1 billion fundLikely to be first domestic PE firm to manage a $1 billion fund; announcement soon
- Claris Lifesciences gets USFDA drug approvalClaris Lifesciences Ltd, a parenteral drug company has received drug approval from US drug authorities for hypertension and angina treatmen...
Load More
